Thu, May 25, 2017 | updated 06:57 AM IST

Post trial scientists develop tablet to prevent kidney cancer relapse

Updated: Oct 12, 2016 12:22 IST      
Post trial scientists develop tablet to prevent kidney cancer relapse

Washington D.C [USA], Oct. 12 (ANI): A recent trial demonstrates that consuming oral tablet Sunitinib for one year reduces the likelihood of cancer returning for kidney cancer patients following removal of the

kidney.

Reportedly, it is the first ever preventative treatment to make a difference to kidney cancer patients after surgery.

Patients with locally advanced kidney cancer usually face a 40 to 50 percent chance of a relapse within five years after having an operation to remove their kidney.

The clinical trial of an adjuvant treatment for patients, who have had kidney cancer, has been carried out by an international team of oncology experts.

The results of the trial are likely to change clinical practice worldwide.

Kidney cancer accounts for 129,000 deaths worldwide each year and patients with locally advanced kidney cancer face a 50 percent risk of it returning within five years once they have had the operation to

remove their kidney.

While adjuvant treatments are routinely used on patients with other types of cancer (such as breast and bowel cancer), no such treatment capable of improving outcomes for kidney cancer patients have been developed yet.

This is despite numerous studies being carried out in this field over the past 20 years.

The recent research demonstrates that by taking the oral tablet Sunitinib for one year, patients are able to reduce the likelihood of their cancer returning.

The trial, a randomised double blind test was conducted with 615 people with stage T3 renal cell carcinoma, some of whom were given Sunitinib and some a placebo.

Patients receiving Sunitinib had improved disease free survival versus those given the placebo (6.8 years versus 5.6 years).

Sunitinib is a tried and tested drug which has been used on patients with metastatic (widespread) renal cancer for around eight years.

In the trial, as expected, the incidence of side-effects in patients taking Sunitinib was higher to those taking the placebo but these side effects were manageable and did not lay impact on the patients' quality of life.

The trial was led in the UK by Hardev Pandha and its lead researcher was Alain Ravaud.

"This trial was undertaken with a very well-defined population of patients who are generally at high risk of relapse. For these patients, it has shown that taking a simple tablet makes a significant difference without causing a significant decrease in quality of life. Since Sunitinib is already widely used in patients with metastatic

cancer, clinicians are familiar with the drug and its side-effects, so are well placed to prescribe it to patients," Pandha said.

The results of the trial were presented during the Presidential Address of the ESMO 2016 Congress in Copenhagen. (ANI)

London [UK], May 24 (ANI): Sleep is the easiest thing to forego by hardworking individuals. What we don't realize is, when sleep fails, one's health declines along with the quality of life.

Full Story >>

Washington D.C. [USA], May 24 (ANI): According to a recent study, adequate levels of Vitamin D combined with good sleep can help you manage chronic arthritis and back pain.

Full Story >>

Washington D.C. [USA], May 24 (ANI): You might consider yourself to be a recreational user but could be further along the road to drug addiction than you might have realized, a study suggests.

Full Story >>

Washington D.C. [USA], May 24 (ANI): A recent study shows a multi-protein biomarker blood test to detect breast cancer can potentially reduce use of biopsy up to 67percent.

Full Story >>

Childhood obesity results in early onset of arthritis

Updated: May 24, 2017 09:32 IST     

New Delhi [India], May 7 (ANI): Obesity, which is assuming epidemic proportions among children, is proving too much on their delicate bones and joints.

Full Story >>

Washington D.C. [USA], May 24 (ANI): A team of researchers has found that intestinal fungi, chronic liver damage, increase risk of death for the people with alcohol-related liver disease.

Full Story >>

Here's what dentists can tell about your health

Updated: May 23, 2017 16:46 IST     

Washington D.C. [USA], May 23 (ANI): A recent study has found that by using medical and dental records, researchers can identify what is the cause of disease and how the patients with certain diseases will respond to surgery, medication or other interventions.

Full Story >>

Trying to lose weight? Dieting may not help

Updated: May 23, 2017 15:08 IST     

Washington D.C. [USA], May 23 (ANI): Dieting has a little effect on losing weight, as a study finds that brain cells act as a trigger to prevent us burning calories when food is scarce.

Full Story >>

Washington D.C. [USA], May 23 (ANI): A study finds that late middle-aged people, with a family history and longer version of mitochondrial gene, encountered twice as much memory loss up to 10 years later as someone with a family history and a short version of the gene.

Full Story >>

New Delhi [India], May 22 (ANI): Global nutrition company Herbalife Nutrition undertook a survey on balanced nutrition in 12 markets across Asia Pacific and surveyed more than 6,000 consumers to understand eating habits, exercise and lifestyle habits among them.

Full Story >>

New device could detect inflammation in lungs

Updated: May 22, 2017 15:23 IST     

New Delhi [India], May 22 (ANI): To improve the management of asthma and other respiratory diseases, researchers have created a graphene-based sensor that could lead to earlier detection of looming asthma attacks.

Full Story >>

Clinical trial gives hope to lung disease patients

Updated: May 22, 2017 13:13 IST     

Washington D.C. [USA], May 22 (ANI): A 'game changing' clinical trial has given hope to patients with severe lung disease.

Full Story >>

Even moderate drinking may not keep heart disease at bay

Updated: May 22, 2017 12:29 IST     

Washington D.C. [USA], May 22 (ANI): If you feel having a glass of wine with dinner or moderately consuming any kind of alcohol is going to save you from heart disease, then you might have to think over it again!

Full Story >>

You may blame the polluted air for disrupted sleep!

Updated: May 22, 2017 11:43 IST     

Washington D.C. [USA], May 22 (ANI): If you are not having a sound sleep, then there might be fault in the air!

Full Story >>

Washington D.C. [USA], May 21 (ANI): A study has found that people aged between 18 to 49, with high systolic blood pressure over 140, are at greater risk of stroke, damage of kidneys and brain.

Full Story >>

Washington D.C. [USA], May 7 (ANI): A study has found that heart failure patients with a history of strokes are at a greater risk of depression, hospitalisation and death than those without such a history.

Full Story >>

Washington D.C. [USA], May 21 (ANI): More than one third of 1,400 people with high blood pressure have not been taking their blood pressure medication, according to a recent study.

Full Story >>

Overweight boys at greater risk of cancer in adulthood

Updated: May 21, 2017 07:53 IST     

Washington D.C. [USA], May 21 (ANI): Parents, take care of your son's weight, as a study finds that if your son is over-weight at age seven, he may be at greater risk of colon (bowel) cancer in adulthood.

Full Story >>

New blood find can help end platelet shortages

Updated: May 21, 2017 06:32 IST     

Washington D.C. [USA], May 21 (ANI): A new discovery may be the key to stopping shortages of these vital blood-clotting cells that can represent the difference between life and death.

Full Story >>

Now, a tablet that may help with heart failure management

Updated: May 21, 2017 05:47 IST     

Washington D.C. [USA], May 21 (ANI): Technology-enabled learning has gone a step further as a novel tablet is helping heart failure patients to manage their disease including drug dosages.

Full Story >>